Previous close | 330.00 |
Open | 330.89 |
Bid | 304.12 x 200 |
Ask | 357.25 x 200 |
Day's range | 330.32 - 330.90 |
52-week range | 157.00 - 331.58 |
Volume | |
Avg. volume | 1,111,222 |
Market cap | 12.411B |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | 85.64 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Shockwave Medical's (SWAV) first-quarter results reflect robust revenue growth and gross margin expansion amid JNJ entering into a definitive agreement to acquire the company.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Insightful Analysis of Shockwave Medical's Position in the Cardiovascular Device Market